ACE2 levels are altered in comorbidities linked to severe outcome in COVID-19

Aims: Severity of outcome in COVID-19 is disproportionately higher among the obese, males, smokers, those suffering from hypertension, kidney disease, coronary heart disease (CHD) and/or type 2 diabetes (T2D). We examined if serum levels of ACE2, the cellular entry point for the coronavirus SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Emilsson, Valur, Gudmundsson, Elias F, Aspelund, Thor, Jonsson, Brynjolfur G, Gudjonsson, Alexander, Launer, Lenore J, Lamb, John R, Gudmundsdottir, Valborg, Jennings, Lori L, Gudnason, Vilmundur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276056/
https://www.ncbi.nlm.nih.gov/pubmed/32511628
http://dx.doi.org/10.1101/2020.06.04.20122044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276056/
https://www.ncbi.nlm.nih.gov/pubmed/32511628
http://dx.doi.org/10.1101/2020.06.04.20122044

Ejemplares similares